Stocks
Tandem Diabetes Care, Inc.TNDM
NASDAQHealthcareMedical Devices$18.31+3.43%
Price as of · delayed, not real-time
A medical device company specializing in insulin pumps and diabetes management technology, Tandem Diabetes Care is closely watched for its innovation in automated insulin delivery systems. Investors monitor its competitive position against larger rivals like Medtronic and Insulet in the growing diabetes care market.
Market Cap: $1.5B52W Range: $11.46-$29.65
Congressional Interest in Tandem Diabetes Care, Inc. (TNDM)
7 members of Congress have disclosed 12 trades in Tandem Diabetes Care, Inc. (TNDM), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
7
Buys
7
Sells
5
Who in Congress Is Trading TNDM?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-09-22 | Josh Gottheimer | buy | $1K-$15K |
| 2025-03-19 | Josh Gottheimer | sell | $1K-$15K |
| 2025-03-04 | Gilbert Cisneros | buy | $1K-$15K |
| 2024-08-05 | Josh Gottheimer | buy | $1K-$15K |
| 2024-05-08 | Josh Gottheimer | buy | $1K-$15K |
| 2023-07-12 | Daniel Goldman | sell | $1K-$15K |
| 2022-05-06 | Rohit Khanna | sell | $1K-$15K |
| 2015-05-27 | Thomas MacArthur | sell | $1K-$15K |
| 2010-07-01 | JAMES B. RENACCI | sell | $557.70 |
| 2009-12-06 | Lamar Smith | buy | $1K-$15K |
| 2009-01-10 | Lamar Smith | buy | $1K-$15K |